Skip to main content
Gencurix Inc. logo

Gencurix Inc. — Investor Relations & Filings

Ticker · 229000 ISIN · KR7229000005 KO Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2025-06-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 229000

About Gencurix Inc.

https://www.gencurix.com/eng/

Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding a decision for a paid-in capital increase (유상증자결정). This document details the issuance of new shares, the purpose of the capital raise (operating funds), the method (third-party allocation), and the pricing details. In the context of financial filings, announcements regarding new share issues, capital changes, or equity financing are classified under 'Share Issue/Capital Change'.
2025-06-12 Korean
소액공모공시서류(지분증권)
Share Issue/Capital Change Classification · 100% confidence The document is a '소액공모공시서류' (Small-scale Public Offering Disclosure Document) filed by Gencurix. It details the issuance of new shares (315,855 common shares) via a third-party allocation method, including the purpose of funds, issuance price, and subscription schedule. This type of filing is a regulatory requirement for small-scale offerings (under 1 billion KRW) in South Korea, which serves as a formal disclosure document for investors. It is not an annual report, earnings release, or simple announcement, but a specific regulatory filing for capital raising.
2025-06-12 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 젠큐릭스' (Gencurix Inc.) covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial data, business operations, research and development activities, and management information, which is characteristic of a formal quarterly financial report. It is not an announcement or a summary, but the full report itself. Q1 2025
2025-05-09 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting held on March 28, 2025, including financial statement approval, director appointments, and other agenda items. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-03-28 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to directors and employees, including exercise prices, vesting periods, and valuation methods. This type of disclosure regarding capital structure changes and equity-based compensation falls under the 'Regulatory Filings' category as it is a specific statutory disclosure requirement in the Korean market that does not fit into the other specialized categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for capital changes).
2025-03-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership by major shareholders and special related parties, including reasons for changes such as stock pledges, share disposals, and adjustments due to stock options. This falls under the category of Major Shareholding Notification.
2025-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.